BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 6243403)

  • 1. Modulation of nicotinic receptors by opiate receptor agonists in cultured adrenal chromaffin cells.
    Kumakura K; Karoum F; Guidotti A; Costa E
    Nature; 1980 Jan; 283(5746):489-92. PubMed ID: 6243403
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Co-release of enkephalin and catecholamines from cultured adrenal chromaffin cells.
    Livett BG; Dean DM; Whelan LG; Udenfriend S; Rossier J
    Nature; 1981 Jan; 289(5795):317-9. PubMed ID: 7453829
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of acetylcholine receptors by endogenous cotransmitters: studies of adrenal medulla.
    Costa E; Guidotti A; Hanbauer I; Hexum T; Saiani L; Stine S; Yang HY
    Fed Proc; 1981 Feb; 40(2):160-5. PubMed ID: 6257555
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Receptors and receptor modulation in cultured chromaffin cells.
    Livett BG; Boksa P
    Can J Physiol Pharmacol; 1984 Apr; 62(4):467-76. PubMed ID: 6203633
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of nicotinic receptor function by opiate recognition sites highly selective for Met5-enkephalin[Arg6Phe7].
    Costa E; Guidotti A; Hanbauer I; Saiani L
    Fed Proc; 1983 Sep; 42(12):2946-52. PubMed ID: 6884531
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence that inhibition of nicotine-mediated catecholamine secretion from adrenal chromaffin cells by enkephalin, beta-endorphin, dynorphin (1-13), and opiates is not mediated via specific opiate receptors.
    Dean DM; Lemaire S; Livett BG
    J Neurochem; 1982 Mar; 38(3):606-14. PubMed ID: 6276506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of opioid compounds on desensitization of the nicotinic response of isolated bovine adrenal chromaffin cells.
    Marley PD; Livett BG
    Biochem Pharmacol; 1987 Sep; 36(18):2937-44. PubMed ID: 2888465
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies on the inhibitory action of opiate compounds in isolated bovine adrenal chromaffin cells: noninvolvement of stereospecific opiate binding sites.
    Lemaire S; Livett B; Tseng R; Mercier P; Lemaire I
    J Neurochem; 1981 Mar; 36(3):886-92. PubMed ID: 6259293
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nicotine stimulates secretion of both catecholamines and acetylcholinesterase from cultured adrenal chromaffin cells.
    Mizobe F; Livett BG
    J Neurosci; 1983 Apr; 3(4):871-6. PubMed ID: 6834109
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proportional secretion of opioid peptides and catecholamines from adrenal chromaffin cells in culture.
    Wilson SP; Chang KJ; Viveros OH
    J Neurosci; 1982 Aug; 2(8):1150-6. PubMed ID: 7108586
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metorphamide, a novel endogenous adrenal opioid peptide, inhibits nicotine-induced secretion from bovine adrenal chromaffin cells.
    Marley PD; Mitchelhill KI; Livett BG
    Brain Res; 1986 Jan; 363(1):10-7. PubMed ID: 3947946
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of opioid peptides containing the sequence of Met5-enkephalin or Leu5-enkephalin on nicotine-induced secretion from bovine adrenal chromaffin cells.
    Marley PD; Mitchelhill KI; Livett BG
    J Neurochem; 1986 Jan; 46(1):1-11. PubMed ID: 2866231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Choline stimulates nicotinic receptors on adrenal medullary chromaffin cells to induce catecholamine secretion.
    Holz RW; Senter RA
    Science; 1981 Oct; 214(4519):466-8. PubMed ID: 7291988
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sigma-1 receptor ligands inhibit catecholamine secretion from adrenal chromaffin cells due to block of nicotinic acetylcholine receptors.
    Brindley RL; Bauer MB; Hartley ND; Horning KJ; Currie KPM
    J Neurochem; 2017 Oct; 143(2):171-182. PubMed ID: 28815595
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interactions of phenoxybenzamine and nicotinic agonists at the nicotinic receptor in the cat adrenal medulla.
    Khan MT; Furchgott RF
    J Pharmacol Exp Ther; 1982 Apr; 221(1):117-22. PubMed ID: 7062277
    [No Abstract]   [Full Text] [Related]  

  • 16. Pharmacological characterization of adrenal paraneurons: substance P and somatostatin as inhibitory modulators of the nicotinic response.
    Mizobe F; Kozousek V; Dean DM; Livett BG
    Brain Res; 1979 Dec; 178(2-3):555-66. PubMed ID: 509217
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of opioid peptides and morphine on histamine-induced catecholamine secretion from cultured, bovine adrenal chromaffin cells.
    Livett BG; Marley PD
    Br J Pharmacol; 1986 Oct; 89(2):327-34. PubMed ID: 3779215
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A role for the opiate peptides that presumably coexist with acetylcholine in splanchnic nerves.
    Kumakura K; Guidotti A; Yang HY; Saiani L; Costa E
    Adv Biochem Psychopharmacol; 1980; 22():571-80. PubMed ID: 6249085
    [No Abstract]   [Full Text] [Related]  

  • 19. Methoxyverapamil reduction of nicotine-induced catecholamine release involves inhibition of nicotinic acetylcholine receptor currents.
    Boehm S; Huck S
    Eur J Neurosci; 1993 Oct; 5(10):1280-6. PubMed ID: 8275230
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanism of the differential effects of halothane on nicotinic- and muscarinic-receptor-mediated responses of the dog adrenal medulla.
    Sumikawa K; Matsumoto T; Ishizaka N; Nagai H; Amenomori Y; Amakata Y
    Anesthesiology; 1982 Dec; 57(6):444-50. PubMed ID: 7149302
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.